These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32945506)

  • 1. Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiation.
    Holzhauser S; Pirotte E; Jones J; Owens D; Al-Hussaini A; Giles P; Evans M; Man S; Powell N
    Oncol Rep; 2020 Oct; 44(4):1717-1726. PubMed ID: 32945506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Wang H; Wang B; Wei J; Meng L; Zhang Q; Qu C; Xin Y; Jiang X
    Int J Biol Sci; 2020; 16(6):1035-1043. PubMed ID: 32140071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.
    Nickson CM; Moori P; Carter RJ; Rubbi CP; Parsons JL
    Oncotarget; 2017 May; 8(18):29963-29975. PubMed ID: 28415784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus.
    Pirotte EF; Holzhauser S; Owens D; Quine S; Al-Hussaini A; Christian AD; Giles PJ; Man ST; Evans M; Powell NG
    PLoS One; 2018; 13(12):e0207934. PubMed ID: 30543656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide.
    Carlander AF; Jakobsen KK; Bendtsen SK; Garset-Zamani M; Lynggaard CD; Jensen JS; Grønhøj C; Buchwald CV
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.
    Lilja-Fischer JK; Ulhøi BP; Alsner J; Stougaard M; Thomsen MS; Busk M; Lassen P; Steiniche T; Nielsen VE; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1489-1494. PubMed ID: 31510843
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
    Shaikh MH; Dawson A; Prokopec SD; Barrett JW; Y F Zeng P; Khan MI; Ryan SEB; Cecchini M; Palma DA; Mymryk JS; Boutros PC; Nichols AC
    Oral Oncol; 2023 Nov; 146():106580. PubMed ID: 37778229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
    Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
    Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
    BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
    Inoue H; Hirasaki M; Kogashiwa Y; Kuba K; Ebihara Y; Nakahira M; Sakai A; Okuda A; Sugasawa M
    Acta Otolaryngol; 2021 Jun; 141(6):640-645. PubMed ID: 33794725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma.
    Kähler J; Hafner S; Popp T; Hermann C; Rump A; Port M; Steinestel K; Eder S
    Int J Mol Med; 2020 Nov; 46(5):1733-1742. PubMed ID: 32901844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.
    Liu C; Mann D; Sinha UK; Kokot NC
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):59. PubMed ID: 30241572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma.
    Yin X; Shan C; Wang J; Zhang H
    Oral Oncol; 2020 Apr; 103():104590. PubMed ID: 32050152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
    Zech HB; Berger J; Mansour WY; Nordquist L; von Bargen CM; Bußmann L; Oetting A; Christiansen S; Möckelmann N; Böttcher A; Busch CJ; Petersen C; Betz C; Rothkamm K; Kriegs M; Köcher S; Rieckmann T
    Radiother Oncol; 2022 Mar; 168():138-146. PubMed ID: 35093407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.